Thank you to NIDA for supporting the co-founding of Myosin Therapeutics (Myosin Therapeutics) by Scripps Research Investigators Courtney Miller, PhD, Pat Griffin and Ted Kamenecka

Excited to announce the launch of Myosin Therapeutics - keep an eye on our race to clinic for #addictionrecovery

"Addiction as a brain disease revised." Check this fresh off the press review by our director Markus Heilig and others! Heilig Lab @lvanderschuren Linköpings universitet nature.com/articles/s4138…

While deaths from opioids continue to be a major public health concern, there is also an alarming increase in deaths involving stimulants in combination with opioids. Learn more about NIDA-funded research efforts underway to address these dual crises. loom.ly/E66ftAk

Myosin Therapeutics team awarded NINDS Translate grant to develop MT-125 for the treatment of #glioblastoma (#GBM) with neuro-oncologist Dr. Steve Rosenfeld Mayo Clinic

James Schaeffer, PhD and Michael Brownstein, MD, PhD join the Myosin Therapeutics Advisory Board, bringing a wealth of knowledge for business and pipeline development

Mayo Clinic neuro-oncologist and recognized leader in the study and treatment of glioblastoma, Steven Rosenfeld, MD, PhD, joins the Myosin Therapeutics Advisory Board to help guide development of MT-125 for the treatment of glioblastoma mayoclinic.org/biographies/ro…

Myosin Therapeutics awarded an Innovation Grant from InnovationtoImpact, NIDAnews and TheRefinery for promising innovators committed to launching #addiction treatments into the marketplace

"Drug overdose deaths rose by 30% in the United States in 2020, hitting the highest number ever recorded, the CDC reported Wednesday. 'Overdose deaths from synthetic opioids and psychostimulants such as methamphetamine also increased in 2020' " cnn.com/2021/07/14/hea…

Myosin Therapeutics selected to be in the 2021-2022 Cohort of NYU Stern School of Business Endless Frontier Labs accelerator program for early stage science and tech startups endlessfrontierlabs.com/about/

EFL is thrilled to kick off the 2021-22 cohort today at Orientation Day! Join us in welcoming 75 groundbreaking startups to the EFL program across Life Sciences, Deep Tech, and Digital Tech tracks. #startups #lifesciences #digitaltech #deeptech

Excited to see our work in cancer and addiction being noticed! labiotech.eu/best-biotech/f…

We're looking forward to participating as a selected presenting company in the Florida Venture Capital Conference in Miami next week #FVCC24MIAMI

Just received the NOA for Phase II of our Fast Track STTR. So grateful to our collaborators Mayo Clinic and to National Cancer Institute for supporting our work to bring a #glioblastoma therapeutic to the clinic